Living donor (LD) kidney transplantation is currently the best treatment for end-stage renal
disease (ESRD) in terms of life expectancy and quality of life. This method allows preemptive
transplantation, before beginning dialysis.
The main objective of this study will be to investigate quality of life and societal
participation in a population of LD kidney transplant recipients comparing preemptive LD
transplantation versus non-preemptive transplantation (performed after a period of dialysis).